Insider Selling: Galectin Therapeutics (NASDAQ:GALT) CFO Sells 25,732 Shares of Stock
Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CFO Jack Callicutt sold 25,732 shares of the stock in a transaction dated Monday, January 5th. The stock was sold at an average price of...